The Board of Directors of Novogene Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.25 CNY | +2.00% | -3.43% | -43.23% |
Apr. 12 | Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 27 | Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.23% | 741M | |
-24.88% | 7.83B | |
+70.87% | 4.32B | |
+1.53% | 2.63B | |
-7.18% | 2.53B | |
-44.62% | 2.29B | |
-12.67% | 1.82B | |
-19.62% | 1.51B | |
+18.85% | 1.22B | |
-43.60% | 1.17B |
- Stock Market
- Equities
- 688315 Stock
- News Novogene Co., Ltd.
- Novogene Co., Ltd. authorizes a Buyback Plan.